Table 1 Patient characteristics before and after propensity score matching for patients with confirmed diagnosis of psoriasis who were prescribed with biologic agents vs. patients with a confirmed diagnosis of psoriasis who were prescribed with non-biologic systemic therapy for a follow-up period of 6 months.
From: Biologic therapy is associated with reduced ocular disease in psoriasis: a real-world study
Characteristic Name | Before PSM | After PSM | ||||||
|---|---|---|---|---|---|---|---|---|
Biological (n = 30,991) | Systemic (n = 35,832) | P | Std diff. | Biological (n = 25,278) | Systemic (n = 25,278) | P | Std diff. | |
Age at Index (mean ± SD) | 47.71 ± 17.04 | 54.54 ± 17.42 | <0.0001 | 0.40 | 51.04 ± 16.23 | 50.45 ± 17.0 | <0.0001 | 0.04 |
White (%) | 22,612 (73.11) | 20,484 (59.38) | <0.0001 | 0.29 | 17,193 (68.02) | 16,704 (66.08) | <0.0001 | 0.04 |
Female (%) | 16,293 (52.68) | 19,088 (55.33) | <0.0001 | 0.05 | 13,603 (53.81) | 13,914 (55.04) | 0.0055 | 0.02 |
Hypertensive diseases (%) | 5923 (19.15) | 8951 (25.95) | <0.0001 | 0.16 | 5603 (22.17) | 5457 (21.59) | 0.1163 | 0.01 |
Hyperlipidemia (%) | 3241 (10.48) | 5087 (14.75) | <0.0001 | 0.13 | 3124 (12.36) | 2957 (11.7) | 0.0224 | 0.02 |
Diabetes mellitus (%) | 2908 (9.4) | 4275 (12.39) | <0.0001 | 0.10 | 2708 (10.71) | 2573 (10.18) | 0.0496 | 0.02 |
Nicotine dependence (%) | 1627 (5.26) | 1849 (5.36) | 0.5732 | 0.00 | 1375 (5.44) | 1349 (5.34) | 0.6085 | 0.00 |
Long term (current) use of systemic steroids (%) | 473 (1.53) | 708 (2.05) | <0.0001 | 0.04 | 436 (1.72) | 369 (1.46) | 0.0173 | 0.02 |
Family history of other specified eye disorder (%) | 10 (0.03) | 19 (0.06) | 0.1677 | 0.01 | 10 (0.04) | 10 (0.04) | 1.0000 | 0.00 |
